208 related articles for article (PubMed ID: 36498937)
1. Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics.
Market M; Tennakoon G; Scaffidi M; Cook DP; Angka L; Ng J; Tanese de Souza C; Kennedy MA; Vanderhyden BC; Auer RC
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498937
[TBL] [Abstract][Full Text] [Related]
2. A Method of Assessment of Human Natural Killer Cell Phenotype and Function in Whole Blood.
Market M; Tennakoon G; Ng J; Scaffidi M; de Souza CT; Kennedy MA; Auer RC
Front Immunol; 2020; 11():963. PubMed ID: 32508837
[TBL] [Abstract][Full Text] [Related]
3. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
Lee JC; Lee KM; Kim DW; Heo DS
J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
[TBL] [Abstract][Full Text] [Related]
4. Platelet-Derived Ectosomes Reduce NK Cell Function.
Sadallah S; Schmied L; Eken C; Charoudeh HN; Amicarella F; Schifferli JA
J Immunol; 2016 Sep; 197(5):1663-71. PubMed ID: 27448586
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
6. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
[TBL] [Abstract][Full Text] [Related]
7. IL-10
Jiang Y; Yang M; Sun X; Chen X; Ma M; Yin X; Qian S; Zhang Z; Fu Y; Liu J; Han X; Xu J; Shang H
BMC Infect Dis; 2018 Feb; 18(1):80. PubMed ID: 29439673
[TBL] [Abstract][Full Text] [Related]
8. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
[TBL] [Abstract][Full Text] [Related]
9. Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients.
Wu X; Xiao Y; Guo D; Zhang Z; Liu M
Front Immunol; 2022; 13():849493. PubMed ID: 35350785
[TBL] [Abstract][Full Text] [Related]
10. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients.
Mirjačić Martinović K; Vuletić A; Mališić E; Srdić-Rajić T; Tišma Miletić N; Babović N; Jurišić V
Growth Factors; 2022 Nov; 40(5-6):231-239. PubMed ID: 36129407
[TBL] [Abstract][Full Text] [Related]
13. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
Du Y; Liu X; Guo SW
Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
Trotta R; Dal Col J; Yu J; Ciarlariello D; Thomas B; Zhang X; Allard J; Wei M; Mao H; Byrd JC; Perrotti D; Caligiuri MA
J Immunol; 2008 Sep; 181(6):3784-92. PubMed ID: 18768831
[TBL] [Abstract][Full Text] [Related]
15. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
16. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
17. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
[TBL] [Abstract][Full Text] [Related]
18. Human NK cell IFN-gamma production is regulated by endogenous TGF-beta.
Meadows SK; Eriksson M; Barber A; Sentman CL
Int Immunopharmacol; 2006 Jun; 6(6):1020-8. PubMed ID: 16644489
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
20. Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.
Pierson BA; Gupta K; Hu WS; Miller JS
Blood; 1996 Jan; 87(1):180-9. PubMed ID: 8547640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
